2001
DOI: 10.7326/0003-4819-135-1-200107030-00005
|View full text |Cite
|
Sign up to set email alerts
|

Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease

Abstract: The data support an independent reduction in mortality and opportunistic events attributable to HAART, even in patients with very advanced HIV disease. However, patients with CMV infection or disease may not have a reduction in new CMV events due to HAART.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

8
319
2
9

Year Published

2002
2002
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 515 publications
(338 citation statements)
references
References 30 publications
8
319
2
9
Order By: Relevance
“…The following changes have been made; The introduction of Anti-Retroviral Therapy (ART) in 1997 altered the course and nature of patients infected with HIV by increasing the duration of asymptomatic infection and increasing life expectancy [2,3]. ART is a combination of medication given to those affected with the disease.…”
Section: Powered By Editorial Manager® and Produxion Manager® From Armentioning
confidence: 99%
“…The following changes have been made; The introduction of Anti-Retroviral Therapy (ART) in 1997 altered the course and nature of patients infected with HIV by increasing the duration of asymptomatic infection and increasing life expectancy [2,3]. ART is a combination of medication given to those affected with the disease.…”
Section: Powered By Editorial Manager® and Produxion Manager® From Armentioning
confidence: 99%
“…Los beneficios de la terapia antiviral pueden verse comprometidos cuando aparecen ciertos factores, como defectos de la inmunidad del huésped, alta capacidad del virus para desarrollar resistencia a los fármacos (13,(17)(18)(19)(20)(21), y pobre cumplimiento del tratamiento. A esto se suma el alto costo y el bajo acceso a los medicamentos en los países en vía de desarrollo, así como la alta toxicidad de los mismos (22,23).…”
unclassified
“…In this survey, 37.5% of the respondents reported accepting patients with a history of opportunistic infections, 25% include them only when they had particular types of infection (esophageal candidiasis) which occurred in a more distant past. However, HAART increased the survival even in patients with a history of opportunistic infections (20,24) . Thus, at present this history does not seem to be a good predictor of survival, as long as the patient is stable, considering the CD4 count and the viral load.…”
Section: Discussionmentioning
confidence: 98%